One Health’s FidoCure is using genomics and AI technology to develop precision oncological treatments, and the work is benefiting human cancer research, writes Jenni Spinner.
Source: Outsourcing Pharma, April 19, 2023. Link.
NOTE: In February 2020, FidoCure’s CEO Christina Kelly Lopes was interviewed on FOX Business Live <Link> where she spoke about cancer in dogs, the company’s technology, advances in genomics and the potential to advance research in research and treatment for human cancers.